Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Oxidation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106045804B enables aqueous asymmetric oxidation. Reduces solvent waste and improves catalyst recovery for pharmaceutical intermediates.
Advanced chiral preparation method for Carfilzomib intermediate ensuring high purity and yield. Optimized for commercial scale-up and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN103788069B reveals advanced asymmetric oxidation for esomeprazole magnesium trihydrate. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Novel asymmetric oxidative coupling method for chiral spiro indolones using cinchona catalysts. High yield, mild conditions, scalable manufacturing for pharmaceutical intermediates.
Patent CN115181081A details a green asymmetric Baeyer-Villiger oxidation using an ionic cobalt complex. This method offers high yield, recyclability, and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104447440B reveals Mn-catalyzed asymmetric oxidation. High purity, green process, supply chain reliability for pharma intermediates.
Novel asymmetric Baeyer-Villiger oxidation for Brivaracetam intermediate. Reduces cost and improves chiral purity for pharmaceutical manufacturing supply chains.
97% ee, >95% yield, low-cost industrial production of chiral alpha-hydroxy-beta-keto esters for agrochemicals. Solve supply chain risks with scalable zirconium catalysis.